SILVERARC CAPITAL MANAGEMENT, LLC - MEDICENNA THERAPEUTICS CORP ownership

MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 26 filers reported holding MEDICENNA THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SILVERARC CAPITAL MANAGEMENT, LLC ownership history of MEDICENNA THERAPEUTICS CORP
ValueSharesWeighting
Q2 2021$333,000
-24.1%
110,515
+2.8%
0.15%
-37.7%
Q1 2021$439,000
-12.7%
107,5360.0%0.24%
-18.2%
Q4 2020$503,000107,5360.29%
Other shareholders
MEDICENNA THERAPEUTICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,272,700$2,647,0000.70%
Worth Venture Partners, LLC 571,489$846,0000.50%
ACT CAPITAL MANAGEMENT, LLC 149,070$173,0000.24%
Verition Fund Management LLC 539,051$631,0000.01%
Sigma Planning Corp 252,050$292,0000.01%
McKinley Carter Wealth Services, Inc. 79,259$92,0000.01%
Patriot Financial Group Insurance Agency, LLC 17,900$21,0000.00%
LETKO, BROSSEAU & ASSOCIATES INC 100,000$116,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 113,000$132,0000.00%
Rathbones Group PLC 40,000$46,0000.00%
View complete list of MEDICENNA THERAPEUTICS CORP shareholders